Pere Llinàs‐Arias

858 total citations
18 papers, 378 citations indexed

About

Pere Llinàs‐Arias is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Pere Llinàs‐Arias has authored 18 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Pere Llinàs‐Arias's work include Cancer Genomics and Diagnostics (8 papers), Epigenetics and DNA Methylation (7 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Pere Llinàs‐Arias is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Epigenetics and DNA Methylation (7 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Pere Llinàs‐Arias collaborates with scholars based in Spain, United States and Sweden. Pere Llinàs‐Arias's co-authors include Manel Esteller, Miquel Ensenyat-Méndez, Diego M. Marzese, Borja Sesé, Maggie L. DiNome, Javier I. J. Orozco, Matthew P. Salomon, Fernando Setién, Verónica Dávalos and David Piñeyro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Pere Llinàs‐Arias

18 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pere Llinàs‐Arias Spain 10 270 120 100 38 35 18 378
Bowen Yuan China 8 301 1.1× 103 0.9× 137 1.4× 75 2.0× 29 0.8× 14 418
Kirat Kumar Ganguly India 8 211 0.8× 89 0.7× 158 1.6× 46 1.2× 64 1.8× 14 416
Rongxia Liao China 10 292 1.1× 245 2.0× 118 1.2× 28 0.7× 32 0.9× 18 429
Xian-Zi Yang China 8 225 0.8× 95 0.8× 95 0.9× 23 0.6× 28 0.8× 8 320
Grinu Mathew United States 10 263 1.0× 101 0.8× 97 1.0× 51 1.3× 41 1.2× 16 360
Robiya Joseph United States 8 244 0.9× 134 1.1× 133 1.3× 67 1.8× 39 1.1× 18 362
Alessandro Carugo United States 11 225 0.8× 115 1.0× 153 1.5× 38 1.0× 44 1.3× 17 362
Linglong Yin China 10 342 1.3× 122 1.0× 144 1.4× 85 2.2× 35 1.0× 17 469
Kieren D. Marini Australia 8 229 0.8× 80 0.7× 118 1.2× 42 1.1× 36 1.0× 9 330
Weimin Hu United States 8 305 1.1× 79 0.7× 188 1.9× 25 0.7× 54 1.5× 10 431

Countries citing papers authored by Pere Llinàs‐Arias

Since Specialization
Citations

This map shows the geographic impact of Pere Llinàs‐Arias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pere Llinàs‐Arias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pere Llinàs‐Arias more than expected).

Fields of papers citing papers by Pere Llinàs‐Arias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pere Llinàs‐Arias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pere Llinàs‐Arias. The network helps show where Pere Llinàs‐Arias may publish in the future.

Co-authorship network of co-authors of Pere Llinàs‐Arias

This figure shows the co-authorship network connecting the top 25 collaborators of Pere Llinàs‐Arias. A scholar is included among the top collaborators of Pere Llinàs‐Arias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pere Llinàs‐Arias. Pere Llinàs‐Arias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ensenyat-Méndez, Miquel, Javier I. J. Orozco, Pere Llinàs‐Arias, et al.. (2025). Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer. npj Precision Oncology. 9(1). 287–287. 1 indexed citations
2.
Llinàs‐Arias, Pere, Miquel Ensenyat-Méndez, Javier I. J. Orozco, et al.. (2024). Hidden secrets of the cancer genome: unlocking the impact of non-coding mutations in gene regulatory elements. Cellular and Molecular Life Sciences. 81(1). 274–274. 1 indexed citations
3.
Ensenyat-Méndez, Miquel, Javier I. J. Orozco, Pere Llinàs‐Arias, et al.. (2023). Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer. SHILAP Revista de lepidopterología. 3(1). 93–93. 7 indexed citations
4.
Ensenyat-Méndez, Miquel, et al.. (2023). Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females. JAMA Network Open. 6(10). e2335821–e2335821. 13 indexed citations
5.
Llinàs‐Arias, Pere, Miquel Ensenyat-Méndez, Javier I. J. Orozco, et al.. (2023). 3-D chromatin conformation, accessibility, and gene expression profiling of triple-negative breast cancer. BMC Genomic Data. 24(1). 61–61. 1 indexed citations
6.
Sesé, Borja, Miquel Ensenyat-Méndez, Pere Llinàs‐Arias, et al.. (2022). Glioblastoma Embryonic-like Stem Cells Exhibit Immune-Evasive Phenotype. Cancers. 14(9). 2070–2070. 9 indexed citations
7.
Torres-Diz, Manuel, Antonio Gómez, Octavio A. Romero, et al.. (2021). MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex. Proceedings of the National Academy of Sciences. 118(37). 7 indexed citations
8.
Llinàs‐Arias, Pere, Kelly McCann, Leonie Voorwerk, et al.. (2021). Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer. Cancers. 13(16). 4139–4139. 20 indexed citations
9.
Sesé, Borja, et al.. (2021). Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncology. Clinical Epigenetics. 13(1). 150–150. 11 indexed citations
10.
Ensenyat-Méndez, Miquel, Pere Llinàs‐Arias, Javier I. J. Orozco, et al.. (2021). Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer. Frontiers in Oncology. 11. 681476–681476. 99 indexed citations
11.
Morey, Jeroni, Pere Llinàs‐Arias, Alberto Bueno-Costa, Alberto J. León, & María de las Nieves Piña. (2021). Raltitrexed-Modified Gold and Silver Nanoparticles for Targeted Cancer Therapy: Cytotoxicity Behavior In Vitro on A549 and HCT-116 Human Cancer Cells. Materials. 14(3). 534–534. 10 indexed citations
12.
Llinàs‐Arias, Pere, Yuriko Sakaguchi, Kenjyo Miyauchi, et al.. (2020). Epigenetic loss of the transfer RNA-modifying enzyme TYW2 induces ribosome frameshifts in colon cancer. Proceedings of the National Academy of Sciences. 117(34). 20785–20793. 37 indexed citations
13.
Parra, Maribel, Maria João Baptista, Eulàlia Genescà, Pere Llinàs‐Arias, & Manel Esteller. (2020). Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute. Hematological Oncology. 38(4). 432–438. 7 indexed citations
14.
Fleischer, Aarne, et al.. (2020). New Bicistronic TALENs Greatly Improve Genome Editing. Current Protocols in Stem Cell Biology. 52(1). e104–e104. 5 indexed citations
15.
Paz, Alexia Martínez de, David Piñeyro, Anna Martínez‐Cardús, et al.. (2019). Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer. Oncogene. 38(45). 7106–7112. 49 indexed citations
16.
Belhadj, Sami, Cátia Moutinho, Pilar Mur, et al.. (2019). Germline variation in O6-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancer. Cancer Letters. 447. 86–92. 13 indexed citations
17.
Pérez-Salvia, Montserrat, Laia Simó‐Riudalbas, Pere Llinàs‐Arias, et al.. (2017). Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer. Oncotarget. 8(31). 51621–51629. 16 indexed citations
18.
Llinàs‐Arias, Pere & Manel Esteller. (2017). Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update. Open Biology. 7(9). 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bowen Yuan Breakdown of academic impact, for papers by Kirat Kumar Ganguly Breakdown of academic impact, for papers by Rongxia Liao Breakdown of academic impact, for papers by Xian-Zi Yang Breakdown of academic impact, for papers by Grinu Mathew Breakdown of academic impact, for papers by Robiya Joseph Breakdown of academic impact, for papers by Alessandro Carugo Breakdown of academic impact, for papers by Linglong Yin Breakdown of academic impact, for papers by Kieren D. Marini Breakdown of academic impact, for papers by Weimin Hu
Rankless by CCL
2026